Health Care · Health Care Equipment
Boston Scientific: revenue, profit and cash flow
In fiscal 2025, Boston Scientific had revenue of $20.1B, up 9.5% a year on average since 2015, and net income of $2.9B (14.4% of revenue). It has 11% more shares than in 2015.
Revenue, fiscal 2025
average annual revenue growth since 2015 · +19.9% vs 2024
- Ticker
- BSX · NYSE
- Sector
- Health Care
- Sub-industry
- Health Care Equipment
- Headquarters
- Marlborough, Massachusetts
- Founded
- 1979
- In the S&P 500 since
- February 24, 1995
- Latest fiscal year
- 2025, ended December 31, 2025
- SEC filer
- Boston Scientific Corp · CIK 0000885725
Revenue and net income
Revenue went from $8.36B in 2007 to $20.1B in 2025. Net loss in 2007–2010, 2012–2015, 2020.
Diluted earnings per share
Diluted EPS went from −$0.33 in 2007 to $1.94 in 2025.
Shares outstanding
11.4% more shares in 2025 than in 2015 (1.34B → 1.49B): new shares outweighed buybacks.
Operating cash flow, capex and free cash flow
Free cash flow (operating cash flow minus capital expenditure) was $3.66B in 2025, 18.2% of revenue. Negative in 2018.
The chart data could not be loaded. The table below has the same figures.
Year by year
| Fiscal year | Revenue | Net income | Net margin | Diluted EPS | Shares | Operating cash flow | Capex | Free cash flow |
|---|---|---|---|---|---|---|---|---|
| 2025 | $20.1B | $2.9B | 14.4% | $1.94 | 1.49B | $4.53B | $876M | $3.66B |
| 2024 | $16.7B | $1.85B | 11.1% | $1.25 | 1.49B | $3.44B | $790M | $2.65B |
| 2023 | $14.2B | $1.57B | 11.0% | $1.07 | 1.46B | $2.5B | $711M | $1.79B |
| 2022 | $12.7B | $642M | 5.1% | $0.45 | 1.44B | $1.53B | $588M | $938M |
| 2021 | $11.9B | $985M | 8.3% | $0.69 | 1.43B | $1.87B | $554M | $1.32B |
| 2020 | $9.91B | −$115M | −1.2% | −$0.08 | 1.42B | $1.51B | $376M | $1.13B |
| 2019 | $10.7B | $4.7B | 43.8% | $3.33 | 1.41B | $1.84B | $461M | $1.38B |
| 2018 | $9.82B | $1.67B | 17.0% | $1.19 | 1.4B | $310M | $316M | −$6.0M |
| 2017 | $9.05B | $104M | 1.1% | $0.08 | 1.39B | $1.43B | $319M | $1.11B |
| 2016 | $8.39B | $347M | 4.1% | $0.25 | 1.38B | $1.18B | $376M | $806M |
| 2015 | $8.07B | −$239M | −3.0% | −$0.18 | 1.34B | $691M | $247M | $444M |
| 2014 | $7.46B | −$119M | −1.6% | −$0.09 | 1.32B | $1.27B | $259M | $1.01B |
| 2013 | $7.07B | −$121M | −1.7% | −$0.09 | 1.34B | $1.11B | $245M | $865M |
| 2012 | $6.96B | −$4.07B | −58.5% | −$2.89 | 1.41B | $1.28B | $226M | $1.05B |
| 2011 | $7.62B | $441M | 5.8% | $0.29 | 1.52B | $1.01B | $304M | $704M |
| 2010 | $7.81B | −$1.06B | −13.6% | −$0.70 | 1.52B | $325M | $272M | $53M |
| 2009 | $8.19B | −$1.02B | −12.5% | −$0.68 | 1.51B | $835M | $312M | $523M |
| 2008 | $8.05B | −$2.04B | −25.3% | −$1.36 | 1.5B | $1.22B | $362M | $854M |
| 2007 | $8.36B | −$495M | −5.9% | −$0.33 | 1.49B | $934M | $363M | $571M |
Fiscal years, labelled by the year in which they end. US dollars; per-share figures and share counts adjusted for splits. —: not in the data.
About these figures
- No dividends per share in the filings data. Usually that means no dividend, but some companies report theirs in a form the data do not capture.
- Older years are as filed at the time and may predate later restatements, mergers or spin-offs. How the figures are made.
Other Health Care Equipment companies
Source: SEC EDGAR (company filings), data as of November 8, 2026. Sectors, sub-industries, headquarters and index dates: Wikipedia, CC BY-SA 4.0.